https://scholars.lib.ntu.edu.tw/handle/123456789/579270
標題: | A rare cause of chylous ascites | 作者: | YI-TING CHEN YUNG-MING CHEN |
公開日期: | 2014 | 卷: | 7 | 期: | 1 | 起(迄)頁: | 71-72 | 來源出版物: | Clinical Kidney Journal | 摘要: | We report a patient with end-stage renal disease status after two renal transplantations. Milky-like ascites was noted since the immunosuppressant agent was switched to sirolimus (1 mg/day). Chylous ascites was diagnosed owing to the triglyceride of dialysate to serum being 15.98:15.99. Series studies were all negative. It is highly suspected that the cause of chylous ascites is sirolimus related because surgically related lymph vessel injury happens most often 6 months after transplantation. Sirolimus-related chylous ascites is a rare cause of chylous ascites but the incidence rate increases after transplantation. Side effects of sirolimus include hyperlipidemia, anemia, thrombocytopenia, hepatotoxicity, delayed wound healing and a high rate of lymphoceles, lymph edema, and pulmonary alveolar proteinosis. Chylous ascitis has improved since the switch from sirolimus to other immunosuppressant agents. ? The Author 2013. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oup.com. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893131558&doi=10.1093%2fckj%2fsft153&partnerID=40&md5=fc97729b65678e69d4c3438e07d4d347 https://scholars.lib.ntu.edu.tw/handle/123456789/579270 |
ISSN: | 2048-8505 | DOI: | 10.1093/ckj/sft153 | SDG/關鍵字: | immunosuppressive agent; rapamycin; triacylglycerol; adult; anasarca; article; case report; catheter removal; chronic graft rejection; chylous ascites; dialysate; drug dose reduction; end stage renal disease; female; human; immunoglobulin A nephropathy; immunosuppressive treatment; kidney dysfunction; kidney graft rejection; kidney transplantation; leukocyte count; middle aged; oliguria; peritoneal dialysis; peritoneal dialysis catheter; priority journal; treatment outcome; triacylglycerol blood level; uremia |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。